Favorable clinical course after early-intensive immunotherapy for new-onset refractory status epilepticus
Background New-onset refractory status epilepticus (NORSE) refers to the newly established concept of a disease characterized by refractory status epilepticus without an identifiable etiology. Recent reports have indicated the importance of immunotherapy for NORSE. Case Report A 37-year-old man with...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
The Korean Neurocritical Care Society
2020-06-01
|
Series: | Journal of Neurocritical Care |
Subjects: | |
Online Access: | http://www.e-jnc.org/upload/pdf/jnc-190115.pdf |